As per Canvallates website
https://www.cannabis-research.com.au/fda-pathway/
FDA is happy to move past the Toxicology Studies
Both component parts of IHL-42X have previous approval IHL-42X is
a combination of dronabinol, which is synthetic THC, and acetazolamide.
This will enable IHL to move faster and use existing studies as a "Bridging" to accelerate its application.
GLAH
